- Advertisement -

SLAS 2024: Advances in Automation, Emerging Trends, and More

Lesley Mathews, PhD, trained as a molecular biologist and worked in big pharma as well as the Broad Institute, where she ran a pharmacology...

Gasification goes green

Rice’s low-temp photocatalyst could slash the carbon footprint for syngas Credit: Photo by Jeff Fitlow/Rice University HOUSTON —...

WEHI collaborates with Boehringer Ingelheim to develop novel anti-cancer therapeutics

WEHI has partnered with Boehringer Ingelheim, a leading research-driven pharmaceutical company, in a collaboration to discover and develop anti-cancer therapeutics using a promising new...

Quotient Sciences Installs GMP Biofoundry-in-a-Box for RNA Production

Quotient Sciences, a CDMO, reports that it has installed Centillion’s Biofoundry-in-a-Box (BiaB), a multi-product GMP platform technology for end-to-end RNA manufacture. BiaB is a...

Scorpion Venom Miniprotein Takes the Sting out of Rheumatoid Arthritis Therapy

Scientists at Fred Hutchinson Cancer Research Center have harnessed a tiny protein found in scorpion venom as a targeted delivery system for carrying steroids...

Researchers identify key gene necessary for cells to consume and destroy...

A team led by UT Southwestern researchers has identified a key gene necessary for cells to consume and destroy viruses. The findings, reported online...

Immune Cell Phenotyping: Cell Surface Architecture Informs Disease Biology

Register Now Erdinc Sezgin, PhD Senior LecturerKarolinska Institutet View Bio ...

Lilly, Ascidian Launch Up-to-$1.9B RNA Exon Editor Collaboration Targeting Inherited Kidney...

Eli Lilly has expanded its genetic medicines pipeline and capabilities, agreeing to partner with Ascidian Therapeutics to develop RNA exon editors intended to treat...

Immune Cell Phenotyping: Cell Surface Architecture Informs Disease Biology

Register Now Erdinc Sezgin, PhD Senior LecturerKarolinska Institutet View Bio ...

Lilly, Ascidian Launch Up-to-$1.9B RNA Exon Editor Collaboration Targeting Inherited Kidney Diseases

Eli Lilly has expanded its genetic medicines pipeline and capabilities, agreeing to partner with Ascidian Therapeutics to develop RNA exon editors intended to treat...

Cross-Reactive T Cells Could Point to Broad Vaccines or Treatments for Measles, Nipah Virus

T cells are some of the immune system’s most important fighters. They can stop tumor growth and fight off severe infections. Scientists at La...

more new items

Immune Cell Phenotyping: Cell Surface Architecture Informs Disease Biology

Register Now Erdinc Sezgin, PhD Senior LecturerKarolinska Institutet View Bio ...

Lilly, Ascidian Launch Up-to-$1.9B RNA Exon Editor Collaboration Targeting Inherited Kidney...

Eli Lilly has expanded its genetic medicines pipeline and capabilities, agreeing to partner with Ascidian Therapeutics to develop RNA exon editors intended to treat...

Cross-Reactive T Cells Could Point to Broad Vaccines or Treatments for...

T cells are some of the immune system’s most important fighters. They can stop tumor growth and fight off severe infections. Scientists at La...